ArticleJournal for immunotherapy of cancer2020

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication.

Erica B Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.